1. Società Italiana di Urologia (SIU)
  2. Società Italiana di Andrologia (SIA)
  3. European Association of Urology (EAU)
  4. European Society for Sexual Medicine (ESSM)
  5. Endourological Society
  6. Urological Research Society (URS)
  7. The Association of Academic European Urologists (AAEU)
  8. Genito-Urinary group of the European Organization for Research and Treatment of Cancer (EORTC)
  9. American Association of Genito-Urinary Surgeoens (AAGUS)
  • Membro del Gruppo di studio italiano per le disfunzioni sessuali femminili, Società Italiana di Andrologia (SIA, 2006).
  • Membro della Commissione Clinica, “Meetings of the European Society for Sexual Medicine (ESSM)”, 2006-2008.
  • Membro del Comitato Scientifico del“Sexual Rehabilitation After Treatment For Prostate Cancer” del “Third International Consultation on Sexual Dysfunctions”, International Consultation on Urological Diseases (ICUD), Parigi, 2009.
  • Membro del Comitato Scientifico M.I.R.R.O.R. (Multicenter Italian report on radical prostatectomy: Outcome and Research) della fondazione L.U.N.A. (Leading Urological No profit Advanced Research) della Societò Italiana di Urologia (SIU) nel 2010.
  • Responsabile del Follow-up dopo trattamento per neoplasi prostatica, Linee guida Regionali, Lombardia dal 2011.
  • Membro del comitato Scientifico della Società Italiana di Urologia dal 2010
  • Membro del Scientific Congress Office (SCO) della European Association of Urology (EAU), dal 2011.
  • Membro della Faculty of the European School of Urology (ESU), dal 2011.
  • Membro dello Young Academic Urologists Group (YAUG) della European Association of Urology (EAU) dal 2011.
  • Membro del comitato scientifico del 17° ECCO-38° ESMO- 32° ESTRO European Cancer Congress, 2013.
  • Membro dell’International Clinical Cancer Research Committee (CIR2C) for Grants, National Institute of Cancer (INCA), Francia, 2013-2015.
  • Membro dell’Expert Review Panel for National Grants, Cancer Research UK, Ottobre 2012.
  • International Reviewer, National Grants, Swiss National Science Foundation, 2012 e 2017.
  • International Reviewer, German Research Foundation (DGF), 2014-2015.
  • International Reviewer, Research Foundation Flanders (FWO), 2015.
  • International Reviewer, Clinical Cancer Research Committee (CIR2C) for Grants, National Institute of Cancer (INCA), 2017.
  • Chairman del Comitato Scientifico dell’EMPaCT group (European Multicenter Prostate Cancer Clinical and Translational Research Group), dal 2012.
  • Membro dell Comitato Scientifico dell’EMUC (European Multidisciplinary Meeting on Urological Cancer), dal 2013.
  • Membro del Comitato “Minimally invasive Lymphadenectomy in Minimally Invasive Surgery in Urology (MISU)”, International Consultation on Urological Diseases – European Association of Urology (ICUD-EAU), 2013-2014.
  • Membro del Prostate Cancer Committee on Cytotoxic chemotherapy and targeted agents, International Consultation on Urological Diseases – European Association of Urology (ICUD-EAU), 2013-2014.
  • Membro dell’International Consortium for Health Outcomes Measurement (ICHOM), Group on Standard Set for Localized Prostate Cancer, 2015.
  • Membro del tavolo dell’European Association of Urology (EAU) Section of Uropathology (ESUP).
  • Membro associato dell’European Association of Urology (EAU) Section of Urological Imaging (ESUI).
  • Membro associato dell’European Association of Urology (EAU) Section of Oncological Urology (ESOU).
  • Chairman del Prostate cancer sub-committee, European Association of Urology (EAU) Section of Oncological Urology (ESOU).
  • Insegnante dell’European Urology Residents Education Programme (EUREP), 2014-18.
  • Membro dello Scientific Committee, Global Congress on Prostate Cancer, 2015.
  • Membro del Pasadena Consensus Panel on Robotic Assisted Radical Prostatectomy, 2015.
  • Membro dell’Impact Assessment of Guidelines Implementation and Education (IMAGINE) group, European Association of Urology (EAU) guidelines, dal 2015.
  • Membro dell’European Association of Urology (EAU) Guideline Office Board, dal 2015
  • Membro dell’European Association of Urology (EAU) Press Committee, dal 2015.
  • Ospite del The American Association of Genitourinary Surgeons (AAGUS), al Meeting del 2016.
  • Membro della Scientific Committee, European Association of Urology (EAU) update on prostate cancer Meeting di Settembre 2017.
  • Membro dell’European School of Oncolgy (ESO) core faculty, Surgical Oncology – Section of Genitourinary cancer
  1. Lancet
  2. Lancet Oncology
  3. Journal of Clinical Oncology
  4. Cancer
  5. European Urology
  6. European Journal of Cancer
  7. Clinical Cancer Research
  8. The Journal of Urology
  9. British Journal of Urology International
  10. Nature Clinical Practice in Urology
  11. International Journal of Clinical Practice
  12. World Journal of Urology
  13. The Journal of Sexual Medicine
  14. International Journal of Urology
  15. Neurourology and Urodynamics
  16. Prostate Cancer and Prostatic Disease
  17. Radiotherapy and Oncology
  18. International Journal of Radiation Oncology, Biology, Physics
  19. Archives of Medical Science
  20. Canadian Journal of Surgery
  21. Journal of Cancer Research and Clinical Oncology
  22. PLOS One
  23. Molecular Cancer Therapeutics
  24. European Journal of Nuclear Medicine and Molecular Imaging
  25. Journal of Clinical Epidemiology
  26. Supportive Care in Cancer
  27. OncoTargets and Therapy
  28. Clinical Genitourinary Cancer
  29. Acta Oncologica
  1. Vincitore nel 2009 del grant del Ministero della Salute per Giovani Ricercatori nell’ambito del tumore della prostata per il progetto intitolato: “Assessment of individual genetic profile in young individuals with and without family history of prostate cancer: implications for individualized prostate cancer screening programs” (GR-2009-10608159), (Euro: 189.000).
  2. Vincitore nel 2011 del grant dell’ESSM (European Society for Sexual Medicine) per la ricerca medica con il progetto intitolato: “Potential neuroprotective effects of a cannabinoid 2 receptor agonist in a rat model of cavernous nerve crush injury” (Euro: 50.000).
  3. Vincitore del grant per la ricerca, Sandoz Biopharmaceuticals, con il progetto intitolato: Mechanisms of resistance to anti-androgen therapies in prostate cancer (Euro: 20.000), 2015.
  4. Vincitore del grant per la ricerca, Sandoz Biopharmaceuticals, con il progetto intitolato: Role of macrophages in shaping disease progression in node-positive prostate cancer (Euros: 40.000), 2016.
  5. Membro del team Prostate Cancer Outcomes: Global Initiative to Compare & Reduce Variation (PCO-CRV protocol) – Movember Foundation (Euros: 75.000), 2016-2018
  6. Premi dell’European Society for Sexual Medicine (ESSM) per la migliore presentazione al Meeting selle difunsioni sessuali maschili (Clinical Science): “Five years follow-up of plaque incision and vein grafting for Peyronie’s disease”. Awarded during the European Society for Sexual Medicine meeting in Instanbul, 2003.
  7. Eletto nel Febbraio 2008 come “Reviewer of the Month” dalla rivista “European Urology”.
  8. Premio come miglior poster della sessione al 21° Meeting dell’European Association of Urology (EAU) (April 5th-8th 2006, Paris, France). Per il poster dal titolo: “A critical appraisal of the ability of body mass indes (BMI) to predict high grade prostate cancer (PCa)”.
  9. Premio come miglior poster della sessione al 24° Meeting dell’European Association of Urology (March 17th-21th, 2009, Stockholm, Sweden). Per il poster dal titolo: “Adjuvant radiotherapy has a positive impact on cancer-specific survival of lymph node positive prostate cancer patients. Results of a matched analysis of a two-institution series with 703 lymph node positive patients”.
  10. Premio come miglior poster della sessione al 24° Meeting dell’European Association of Urology (March 17th-21th, 2009, Stockholm, Sweden) con il poster dal titolo: “Which is the optimal timing of erectile function assessment after bilateral nerve sparing radical prostatectomy? Results from a prospective analysis”.
  11. Premio come miglior poster della sessione al 24° Meeting dell’European Association of Urology (March 17th-21th, 2009, Stockholm, Sweden) con il post dal titolo: “Pelvic lymph node dissection should be omitted in low risk prostate cancer patients. Results of a matched analysis”.
  12. Premio come miglior poster della sessione al 24° Meeting dell’European Association of Urology (March 17th-21th, 2009, Stockholm, Sweden) con il poster dal titolo: “A novel nomogram predicting a positive [11c] choline positron emission tomography/computed tomography (PET/TC) scan in patients with biochemical recurrence after radical prostatectomy”.
  13. Premio come miglior poster della sessione al 26° Meeting dell’European Association of Urology (EAU) (March 18th-22nd, 2011, Vienna, Austria) con il poster dal titolo: “Adjuvant radiotherapy leads to superior recurrence free survival compared to early salvage radiotherapy in patients with locally advanced prostate cancer: Results from a matched-controlled multi-institutional analysis”.
  14. Premio come miglior poster della sessione al 26° Meeting dell’European Association of Urology (EAU) (March 18th-22nd, 2011, Vienna, Austria) con il poster dal titolo: “Development and internal validation of nomograms predicting prostate cancer specific survival in patients with high risk disease. Results of a multi-institutional analysis”.
  15. Premio come miglior poster della sessione al Meeting annuale dell’American Urological Association (May 29th- June 3rd, 2010, San Francisco, CA, USA) con il poster dal titolo: “Predicting favourable pathological outcome in patients with clinical high risk prostate cancer. a novel nomogram based on a multi-institutional analysis”.
  16. Premio come miglior poster della sessione al Meeting annuale dell’American Urological Association (May 14th-19th, 2011, Washington DC, CA, USA) con il poster dal titolo: “Adjuvant radiotherapy leads to superior biochemical recurrence free survival compared to early salvage radiotherapy in patients with locally advanced prostate cancer: results of a matched-controlled multi-institutional analysis”.
  17. Premio come miglior poster della sessione al Meeting annuale dell’American Urological Association (May 14th-19th, 2011, Washington DC, CA, USA) con il poster dal titolo: “Does biochemical progression after radical prostatectomy and adjuvant radiotherapy for locally advanced prostate cancer invariably impact cancer-specific mortality?”
  18. Vincitore nel Marzo 2011 dell’ESUI Vision Award 2011 per il progetto intitolato: “The value of Computed Tomography in predicting prostate cancer lymph node invasion is negligible even in contemporary patients with very high risk of nodal metastases” presented during the26th Meeting of the European Association of Urology (March 18th-22th, 2011, Vienna, Austria).
  19. Premio per il progetto con il più alto contributo al congresso annuale della American Urological Association (AUA) (May16th-21st, 2014, Orlando, FL, USA), con il progetto intitolato: “The impact of time to biochemical recurrence on cancer specific mortality in patients with high risk prostate cancer treated with radical prostatectomy: a competing risks regression analysis”.
  20. Vincitore del premio Matula per il giovane Urologo (<40 anni) con il miglior curruculm scientifico, Società Italiana di Urologia (SIU), Ottobre 2015.
  21. Vincitore dell’European Association of Urology (EAU) Crystal Matula Award, per il giovane Urologo (<40 anni) con il miglior curruculm scientifico, European Association of Urology (EAU), Marzo 2016.
  • Editor in Chief, European Urology Oncology
  • Co-Editor, European Urology Focus (2015-2017)
  • Member, Editorial Board, World Journal of Urology
  • Member, Editorial Board, The Annals of Urology
  • Member, Editorial Board, The Scientific World Journal (Urology section)
  • Member, Editorial Board, European Medical Journal
  • Member, International Editorial Committe, Urologic Oncology section, Archivos Espanoles de Urologia
  • Member, Editorial Board, BioMed Research International
  • Member, Editorial Committee, Minerva Urologica e Nefrologica

Contatti – Studio Privato

Discipline Urologiche Andrologiche Milanesi (DUAM)

Via Fontana, 2, 20122 Milano

tel: +390276316689

Fax:+390276010185

Contatti – Ospedale San Raffaele

Unità Operativa di Urologia Ospedale San Raffaele

Via Olgettina 60, 20132 Milano

Tel. +390226432643

Fax. +390226437298

Gentile Paziente

In considerazione della situazione di emergenza sanitaria legata al COVID 19 – Corona Virus, e’ ora altamente raccomandabile essere visitati per via telematica rimanendo al proprio domicilio.

Questi sono i passaggi necessari:

1. Telefonare oppure inviare email allo studio DUAM (tel 02 7631 6689 – indirizzo email: prenotazioni@duam.it) per richiedere appuntamento per la visita specialistica

2. La segreteria DUAM fornira’ un appuntamento preciso (giorno e ora) per la visita. Verranno fornite le informazioni necessarie a fare pervenire per via telematica la documentazione clinica necessaria alla valutazione del caso (es: esami di laboratorio, radiografie, ecografie, TC, RM, esami specialistici di qualsiasi tipo, fotografie).

3. La visita verra’ eseguita per via telematica ed Suo quadro clinico verra’ valutato in modo da porterLa aiutare al meglio

In attesa di poterLa sentire di persona porgo i saluti più cordiali

Prof. Alberto Briganti

Prenota ora online